Benzinga - Gainers
- Troika Media Group Inc (NASDAQ: TRKA) shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday.
- Owlet Inc (NYSE: OWLT) rose 45.3% to $0.50 in pre-market trading after reporting a $30 million private placement financing.
- Sigma Lithium Corp (NASDAQ: SGML) rose 26.7% to $37.35 in pre-market trading. Sigma Lithium, during January, filed NI 43-101 technical report for production expansion supporting the previously announced 60% increase in
- mineral reserves and $15.3 billion NPV.
- Arbe Robotics Ltd (NASDAQ: ARBE) rose 19.5% to $5.20 in pre-market trading after gaining 12% on Friday.
- Actinium Pharmaceuticals Inc (NYSE: ATNM) rose 18% to $16.24 in pre-market trading. Actinium recently signed a cooperative research and development agreement with National Cancer Institute to further enhance clinical and non-clinical development of actimab-A for the treatment of acute myeloid leukemia and other hematologic malignancies.
- Apellis Pharmaceuticals Inc (NASDAQ: APLS) shares rose 13.4% to $62.99 in pre-market trading after the company said that the FDA approved SYFOVRE as first and only treatment for geographic atrophy.
- Connexa Sports Technologies Inc (NASDAQ: CNXA) rose 11.7% to $0.27 in pre-market trading.
- Aurora Mobile Ltd - ADR (NASDAQ: JG) shares rose 10.3% to $0.75 in pre-market trading. Aurora Mobile recently partnered with Shengshi Dalian Automobile to explore automobile butler service market.
- MDxHealth SA - ADR (NASDAQ: MDXH) rose 9.2% to $4.29 in pre-market trading. The company, last month, reaffirmed FY23 sales guidance of $65 million to $70 million.
- Zedge, Inc. (NYSE: ZDGE) rose 7% to $2.89 in pre-market trading. Zedge, during December, posted a Q1 loss of $0.01 per share.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- iBio, Inc. (NYSE: IBIO) shares fell 13.5% to $1.28 in pre-market trading. iBio shares jumped over 97% on Friday after the company announced MUC16 as its latest immune-oncology target program.
- Vinco Ventures, Inc. (NASDAQ: BBIG) shares dropped 11.4% to $0.5110 in pre-market trading. VVIP Ventures recently entered into an Asset Purchase Agreement with magazine publisher a360 Media to acquire the National Enquirer, the National Examiner and Globe. VVIP Ventures is a joint venture between Vinco Ventures and ICON Publishing, LLC.
- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) fell 10% to $0.7140 in pre-market trading after climbing over 10% on Friday.
- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) fell 9.7% to $0.2799 in pre-market trading after jumping 20% on Friday.
- JD.com, Inc. (NASDAQ: JD) fell 8.1% to $48.72 in pre-market following a media report that the company is planning a $1.5 billion subsidy campaign to compete against rivals.
- OKYO Pharma Limited (NASDAQ: OKYO) fell 7.7% to $3.45 in pre-market trading after surging 58% on Friday. OKYO Pharma, during December, announced U.S. FDA clearance of IND application for OK-101 for the treatment of dry eye disease.
- GeneDx Holdings Corp. (NASDAQ: WGS) fell 7.7% to $0.48 in pre-market trading.
- EBET, Inc. (NASDAQ: EBET) fell 6.4% to $0.55 in pre-market trading. EBET shares gained over 10% on Friday following strong Q4 results and guidance from DraftKings.
- SciSparc Ltd. (NASDAQ: SPRC) fell 5.5% to $0.9452 in pre-market trading. SciSparc shares gained around 10% on Friday after the company announced its MitoCareX Bio joint venture achieved achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement.
- NexImmune, Inc. (NASDAQ: NEXI) shares fell 5.1% to $0.5599 in pre-market trading. NexImmune recently announced data showing AIM ACT T cells enhance the response to bispecific T cell engager therapy at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.